Sex Differences in E-cig Perception: Study 1
Launched by YALE UNIVERSITY · Jun 21, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Sex Differences in E-cig Perception: Study 1," is looking at how men and women may experience e-cigarettes differently. Researchers want to understand how the flavors of e-cigarettes, specifically sweet and cooling flavors, affect people's feelings and attraction to them, particularly in people who already smoke cigarettes and have used e-cigarettes recently.
To participate, you need to be between 21 and 44 years old, currently smoke cigarettes, and have used e-cigarettes at least ten times in the past six months. You should also be willing to avoid nicotine or tobacco for about 6-8 hours before your lab visit. The study is currently recruiting participants, and it's important to note that those with certain health conditions or who are pregnant are not eligible to join. If you qualify and decide to participate, you'll have the opportunity to help researchers learn more about how different people perceive e-cigarettes, which could lead to better support for those dealing with nicotine addiction.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 21-44 years old
- • Able to read/write
- • Current cigarette smoking
- • Recent E-cig Exposure (\>/= 10 uses in past 6 mo.)
- • Urine cot \>200ng/ml
- • Willing to abstain from nicotine/tobacco 6-8hrs prior to lab session
- • Not looking to quit
- Exclusion Criteria:
- • Untreated chronic medical conditions
- • Non-stable Rx medication
- • Illicit drug use
- • Pregnant, trying to become pregnant, breastfeeding
- • Not fully vaccinated for Coronavirus (e.g. COVID-19)
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Patients applied
Trial Officials
Danielle Davis
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials